New York State Common Retirement Fund’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

New York State Common Retirement Fund’s Portfolio EVLO Stock Details EVLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-13	Closed	-$1K	–	3535
2022 Q2	$1K	Sell	13 -775	-98%	-$35.9K	﹤0.01%	3455
2022 Q1	$53K	Hold	788	–	–	﹤0.01%	3157
2021 Q4	$96K	Buy	788 +289	+58%	+$48.8K	﹤0.01%	3085
2021 Q3	$70K	Sell	499 -866	-63%	-$172K	﹤0.01%	3210
2021 Q2	$375K	Buy	1,365 +345	+34%	+$87K	﹤0.01%	2752
2021 Q1	$218K	Buy	1,020 +480	+89%	+$133K	﹤0.01%	2806
2020 Q4	$131K	Hold	540	–	–	﹤0.01%	2912
2020 Q3	$57K	Hold	540	–	–	﹤0.01%	3112
2020 Q2	$53K	Hold	540	–	–	﹤0.01%	3147
2020 Q1	$41K	Hold	540	–	–	﹤0.01%	3022
2019 Q4	$44K	Hold	540	–	–	﹤0.01%	3142
2019 Q3	$66K	Hold	540	–	–	﹤0.01%	3122
2019 Q2	$97K	Hold	540	–	–	﹤0.01%	3127
2019 Q1	$86K	Buy	540 +175	+48%	+$34.6K	﹤0.01%	2989
2018 Q4	$95K	Hold	365	–	–	﹤0.01%	2976
2018 Q3	$89K	Hold	365	–	–	﹤0.01%	3061
2018 Q2	$86K	Buy	+365	New	+$106K	﹤0.01%	3108

Other funds holding EVLO

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

New York State Common Retirement Fund's EVLO Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q3 2022, closing a stake of 13 shares — an estimated $1K sold.

New York State Common Retirement Fund first reported a position in EVLO in Q2 2018 and held it in 17 quarters. The position peaked at $375K in Q2 2021. 41 funds tracked by Wall St. Rank hold EVLO as of Q3 2022.

New York State Common Retirement Fund reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
New York State Common Retirement Fund sold 13 Evelo Biosciences, Inc. Common Stock shares in Q3 2022, an estimated $1K.
New York State Common Retirement Fund first reported a position in Evelo Biosciences, Inc. Common Stock in Q2 2018 and held it in 17 quarters.
New York State Common Retirement Fund's Evelo Biosciences, Inc. Common Stock position peaked at $375K in Q2 2021.
41 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.